Mohamed Abdel-Wahab

Showing 1-20 of 26 articles

Outcomes of rotational atherectomy versus modified balloon angioplasty in severely calcified coronary lesions based on target lesion location: a post hoc analysis of the PREPARE-CALC randomised trial

Rheude T, Toelg R, Byrne R, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M

July 17, 2020 | 10.4244/EIJ-D-19-00488

Interventions for valvular disease

Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: feasibility and early clinical outcomes of the BASILICA technique

Kitamura M, Majunke N, Holzhey D, Desch S, Bani Hani A, Krieghoff C, Gutberlet M, Protsyk V, Ender J, Borger MA, Dvir D, Thiele H, Abdel-Wahab M

June 30, 2020 | 10.4244/EIJ-D-20-00386

Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial

Smits P, Laforgia P, Abdel-Wahab M, Neumann F, Richardt G, Boxma-de Klerk B, Lunde K, Schotborgh C, Piroth Z, Horak D, Wlodarczak A, Frederix G, Omerovic E

June 25, 2020 | 10.4244/EIJ-D-20-00012

Coronary interventions

Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis: The COMPARE-ABSORB Randomized Clinical Trial

Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Włodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R

May 26, 2020 | 10.4244/EIJ-D-19-01079

Long-term follow-up of patients with contained annulus ruptures after TAVI: the EuropeaN COntained RupturE (ENCORE) registry

Breitbart P, Minners J, Pache G, Hansson N, Nørgaard B, De Backer O, Søndergaard L, Alsanjari O, Hildick-Smith D, Abdel-Wahab M, Löbig S, Neumann F, Ruile P

May 20, 2020 | 10.4244/EIJ-D-19-00740

Interventions for valvular disease

Quantitative aortography assessment of aortic regurgitation. Insight into a novel technique

Modolo R, Chang C, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben J-P, Rutten M, Pighi M, El Bouziani A, van Mourik M, Lemos P, Wykrzykowska J, Sandoli de Brito Jr F, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem N, de Winter R, Serruys P

November 20, 2019 | 10.4244/EIJ-D-19-00879

TAVI and horizontal aorta: a "no impact" relationship?

Abdel-Wahab M, Kitamura M, Thiele H

October 4, 2019 | 10.4244/EIJV15I9A136

Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry

Modolo R, Chang C, Tateishi H, Miyazaki Y, Pighi M, Abdelghani M, Roos M, Wolff Q, Wykrzykowska J, de Winter R, Piazza N, Richardt G, Abdel-Wahab M, Soliman O, Onuma Y, Van Mieghem N, Serruys P

August 29, 2019 | 10.4244/EIJ-D-19-00362

TAVI and valve performance: update on definitions, durability, transcatheter heart valve failure modes and management

Eltchaninoff H, Durand E, Barbanti M, Abdel-Wahab M

September 7, 2018 | 10.4244/EIJ-D-18-00653

Interventions for valvular disease

Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve

Kim U, Blanke P, Windecker S, Kasel A, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J

August 3, 2018 | 10.4244/EIJ-D-17-01040

Interventions for valvular disease

Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure

Holy E, Kebernik J, Abdelghani M, Stampfli SF, Hellermann J, Allali A, El-Mawardy M, Sachse S, Lüscher T, Tanner F, Richardt G, Abdel-Wahab M

July 20, 2018 | 10.4244/EIJ-D-18-00041

Interventions for valvular disease

Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicentre registry

Kuhn C, Frerker C, Meyer A-K, Kurz T, Schäfer U, Deuschl F, Abdel-Wahab M, Schewel D, Elghalban A, Kuck K, Frey N, Frank D

June 14, 2018 | 10.4244/EIJ-D-17-01153

Interventions for valvular disease

Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation

El-Mawardy M, Schwarz B, Landt M, Sulimov D, Kebernik J, Allali A, Becker B, Toelg R, Richardt G, Abdel-Wahab M

January 20, 2017 | 10.4244/EIJ-D-15-00412

Interventions for valvular disease

One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation

Mehilli J, Jochheim D, Abdel-Wahab M, Rizas K, Theiss H, Spenkuch N, Zadrozny M, Baquet M, El-Mawardy M, Sato T, Lange P, Kupatt C, Greif M, Hausleiter J, Bauer A, Schwarz F, Pichlmaier M, Hagl C, Richardt G, Massberg S

November 20, 2016 | 10.4244/EIJV12I10A213

Interventions for valvular disease

Redo TAVI: initial experience at two German centres

Schmidt T, Frerker C, Alessandrini H, Schlüter M, Kreidel F, Schäfer U, Thielsen T, Kuck K, Jose J, Holy E, El-Mawardy M, Allali A, Richardt G, Abdel-Wahab M

September 18, 2016 | 10.4244/EIJV12I7A144

Coronary interventions

Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program

Abdel-Wahab M, Neumann F, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi J, Widimsky P, Meredith I, Saito S, Richardt G

July 20, 2016 | 10.4244/EIJY15M07_07

Coronary interventions

Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience

Ielasi A, Miyazaki T, Geraci S, Testa L, Abdel-Wahab M, Kawamoto H, Ruparelia N, Sato T, Caramanno G, Bedogni F, Tespili M, Colombo A, Latib A

April 8, 2016 | 10.4244/EIJV11I14A309

Interventions for valvular disease

Transfemoral TAVI devices: design overview and clinical outcomes

Abdel-Wahab M, Jose J, Richardt G

September 17, 2015 | 10.4244/EIJV11SWA33

Selection of TAVI prostheses: do we really have the CHOICE?

Abdel-Wahab M, Richardt G

September 27, 2014 | 10.4244/EIJV10SUA5

Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial

Akin I, Khattab A, Buettner H, Toelg R, Geist V, Neumann F, Richardt G, Abdel-Wahab M

August 19, 2014 | 10.4244/EIJV10I4A79

Latest news

NEW ISSUE

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

August 7, 2020

NEW

Ahead of Print: Coronary Artery Thrombosis in COVID-19

August 7, 2020

Editorial

Coronary collaterals, the natural grafts of CTO lesions

C. Di Mario

August 7, 2020

PCR Trials

TWILIGHT, ONYX ONE, DKCRUSH-V and much more

(The Trials book is supported by Biotronik)

August 11, 2020

Guidance Papers

Guidelines, consensus & position papers

June 25, 2020

Editorial

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

August 7, 2020

JAA

This Week's JAA's: Real-world Use of the Evolut PRO Valve...